Document Detail


Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm.
MedLine Citation:
PMID:  9726476     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Intraarterial papaverine infusions are performed to reverse cerebral arterial vasospasm resulting from subarachnoid hemorrhage, but such infusions may lead to increases in intracranial pressure (ICP). This study was undertaken to determine when ICP monitoring is indicated during papaverine treatment. METHODS: Seventy-eight vessels were treated in 51 sessions in 28 patients with symptomatic vasospasm. ICP, papaverine doses, and infusion rates were recorded during treatment sessions. The procedural data, Hunt and Hess scores, Fisher grades, Glasgow Coma Scale scores, and ages for all subjects were reviewed and analyzed retrospectively. RESULTS: Baseline ICP ranged from 0 to 34 mm Hg. With typical papaverine doses of 300 mg per territory and infusion times ranging from 5 to 60 minutes per vessel, ICP increases above baseline during papaverine infusion ranged from 0 to 60 mm Hg. Significant (> or = 20 mm Hg) ICP increases during therapy were observed even in patients with low baseline ICP and with papaverine infused at the slowest rate. Patients with a baseline ICP of more than 15 mm Hg were much more likely to have significant ICP increases than were patients with a baseline ICP of 0 to 15 mm Hg. Hunt and Hess scores, Fisher grades, age, and Glasgow Coma Scale scores on admission and immediately before treatment did not correlate with ICP increases during papaverine infusion. Patients with ICP increases of more than 10 mm Hg during therapy were more likely to experience adverse clinical events than were patients with ICP increases of < or = 10 mm Hg. Reduction in the rate of papaverine infusion, or termination of infusion, resulted in reversal of drug-induced ICP elevation. CONCLUSION: ICP monitoring during intraarterial papaverine infusions for cerebral vasospasm is recommended for all patients and is particularly important for patients with elevated baseline ICP. Continuous ICP monitoring facilitates safe and time-efficient drug delivery.
Authors:
D T Cross; C J Moran; E E Angtuaco; J M Milburn; M N Diringer; R G Dacey
Related Documents :
2074976 - Relationship between intracranial pressure and the carotid sinus baroreceptor reflex.
12168276 - Optimizing cerebral perfusion pressure during fiberoptic bronchoscopy in severe head in...
24182166 - Unsteady pressure-sensitive paint measurement based on the heterodyne method using low ...
11057036 - The influence of the intraventricular hemorrhage on the intracranial pressure and hemod...
8743516 - Blood pressure and progression of renal failure in the elderly.
15192576 - Hypertension-induced venous valve remodeling.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJNR. American journal of neuroradiology     Volume:  19     ISSN:  0195-6108     ISO Abbreviation:  AJNR Am J Neuroradiol     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-11-18     Completed Date:  1998-11-18     Revised Date:  2008-02-14    
Medline Journal Info:
Nlm Unique ID:  8003708     Medline TA:  AJNR Am J Neuroradiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1319-23     Citation Subset:  IM    
Affiliation:
Department of Radiology, Washington University School of Medicine, St Louis, MO, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Drug Administration Schedule
Glasgow Coma Scale
Humans
Infusion Pumps
Infusions, Intra-Arterial
Intracranial Hypertension / chemically induced
Intracranial Pressure / drug effects*,  physiology
Ischemic Attack, Transient / drug therapy*,  etiology
Monitoring, Physiologic*
Papaverine / administration & dosage,  adverse effects,  therapeutic use*
Retrospective Studies
Safety
Subarachnoid Hemorrhage / complications
Time Factors
Vasodilator Agents / administration & dosage,  adverse effects,  therapeutic use*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-74-2/Papaverine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of microemboli distal to cerebral aneurysms before and after therapeutic embolization.
Next Document:  MR angiography with ultrashort echo time in cerebral aneurysms treated with Guglielmi detachable coi...